Dear readers,
This is the first of three sequential Newsletters dedicated to the wide application of CT imaging in the oncologic setting. The fundamental contribution of the CT technique in improving the accuracy of cancer diagnosis, determining the stage of disease, and assessing the response to therapy and the therapy-related adverse effects will be illustrated in a series of podcasts by Professor Michel Eisenblätter.
Through his voice, in the first set of podcasts presented below, you will be guided to explore the basic principles of CT staging and restaging in modern oncology, to use CT for patient selection for immunotherapy and to adopt the most reliable CT criteria for identifying patients’ response to immunotherapy.
The profound impact of CT technology in the study of the effects of immunotherapy on cancer
patients is described in two recently published papers we have selected for you, while the three cases from the public.pixelentropy.eu/mdct-new archive linked below demonstrate the advantages of contrast-enhanced and unenhanced CT in cancer diagnosis and staging.
As usual, suggestions for topics to be covered in future issues of this newsletter are welcome:
please send us your proposals at editorial@public.pixelentropy.eu/mdct-new.
From the public.pixelentropy.eu/mdct-new team
